Member Info for Ghia

This is trading towards the bottom of the range now will probably track up towards 30p again by end of August. Opportunity for the brave.

Tommy - Can you clarify what exactly you think the board have promised us?

From where I am sitting they haven’t promised anything just that they will endeavour to get on a platform trial this winter.

Gunto - I’ve seen the comms the timing bit is accurate on both accounts. The strive confidence reference is inference from subtle wording changes in dialogue with a key source.

This is cautious optimism from Shoots around involvement with Strive. Early September should reveal all.

Doc - Haha yes I’m sure they are, they all eventually seem to reply though.

Pretty confident on Thursday your hunch will be correct.

Doc - I applaud you for trying. We both probably should have done this a long time ago but how about we just don’t respond directly to Mani. They are beyond reason and trash any sensible debate.

On the topic of David Boulevard perhaps if you try and contact him and ask him directly you will get the answer you are looking for.

Bryosa & Amers thanks for your input and please continue to provide your thoughts everyone’s opinion is most welcome here.

Tommy - Well hopefully the FDA approve the strive protocol and we make our way into it with whatever numbers make sense.

Manifesto - Also get your history right. The FDA simplified the trial protocol due to concerns about placebo dosing betwee one syringe and two syringes due to the switch in nebuliser.

They cropped from 900 patients across 2 arms + 1 placebo.

To a trial with one arm plus placebo. They actually boosted the the numbers on the single arm of the drug vs placebo.

The trial ultimately was underpowered due to the change in SOC and the dominant strain of covid.

If the FDA was advising on sprinter now I would expect a higher patient count.

Tommy - I’d be more comfortable with a 1000+ patient trial stopping early at an interim analysis due to efficacy, than a smaller trial which is relying on the data from every single patient., with little margin for anomalies .

Manifesto - What has got your back up? I took a few days out to let things simmer down and you launch yourself on my first post back.

You are such an idiot and attack the posters that actually have some useful info to share, so now I won’t share it.

Pure idiot.

Also expect Strive update in September not August.

Surely given our prior history anything around the 600 patient mark is just asking for trouble.

Manifesto - Your latest response is very intriguing you are either playing dumb or you really don’t know what I’m referencing.

Manifesto - And what did Stacey say when quizzed on SNG care to tell us Mani?

Tommy - Mani posts many falsehoods which you haven’t been calling up in recent times.

In general I have no issue with your posting even the thread I pointed out earlier you conceded you where wrong once new information came to light.

The irony is this information had been shared widely prior to that but because it came from a different poster which certain people completely write off it was disregarded and that entire thread came to be.

Similar information is available around Strive currently but because of the source it has been totally disregarded.

It’s August so I guess we will find out soon enough. Strive is an obvious choice of platform fingers crossed we work our way onto it.

Tommy - you mean like mani who you seem to come to the aid of pretty consistently?

Tommy - I stand behind that post do you disagree that SNG where not confident? I think they where blindsided just as much as we where.

The ramp in that post was the big pay day statement the last line. I’d refrain from that in hindsight.

Although all of directors probably did get a big pay day regardless through share options etc such is the way of things.

Mani - I’m so active because you are so argumentative you can’t help yourself and to that I can’t help myself.

It’s funny though that your assumption is self fulfilling!

Size82 - That’s the brush she is trying to tar me with.

Looking back through my posts you will see I reduced my holding after the poly TR1 the reasoning I gave was to take advantage of increased volatility.

I was uncertain what effect the Ukraine issues would have on the wider market and obviously we where in a state of flux here.

That move paid of well on a few of my other holdings which Vi’s fairly aggressively on the Ukraine situation.

Here we dropped and I made back a few shares but it was not anything to write home about.

I know a few investors that tried to play a swing trade here but they have since stopped because the trading range is too small to make it profitable.

In short I have more shares now than just after the P3 news and not looking to buy or sell any this year.

Mani - The quickest way to get the share price below 20p is to ramp up news by end of August which fails to materialise.

Pi’s sucked in will panic the big boys will lap up the volatility and buy into the drop on the cheep.

If you want the price to drop you ramp the share up and create false hope. The history on this share shows exactly that missed deadlines imposed by Pi creating volatility in the share.

As for your accusations I have an opinion on timing here that you disagree with. When I voiced it many months ago it disagreed with your agenda and you took a dislike to it.

No amount of posts by the two of us will make the news and inflection points arrive sooner.

So don’t waste your heartbeats on it.

Now I have an actual genuine question to table to you or anyone who has taken the time to properly investigate Strive which I have not.

You claim it is due to start in August is there a specific meeting, webinar, date trigger point that will announce the trial. Or is this just a comment in an email from someone which is their best intentions but liable for slippage?